<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02307214</url>
  </required_header>
  <id_info>
    <org_study_id>CE 2688</org_study_id>
    <nct_id>NCT02307214</nct_id>
  </id_info>
  <brief_title>Tako-Tsubo Cardiomyopathy and Cardiac Syndrome X: New Insights Into the Pathophysiology</brief_title>
  <acronym>ENDAUT</acronym>
  <official_title>Tako-Tsubo Cardiomyopathy and Cardiac Syndrome X: New Insights Into the Pathophysiology of Two Orphan Cardiac Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale San Giovanni Bellinzona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale San Giovanni Bellinzona</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tako-Tsubo Cardiomyopathy (TTC) and Cardiac Syndrome X (CSX) are respectively acute and
      chronic cardiac conditions whose clinical presentation, mimicking the onset of acute
      myocardial ischemia in absence of epicardial coronary disease, has progressively gained the
      interest of the scientific community. However, despite significant progress, their underlying
      pathophysiology, which seems to evoke some similarities, still remains elusive. Endothelial
      dysfunction and autonomic imbalance have both been individually implied in their puzzling
      pathogenesis.

      The investigators plan to conduct our study in a cohort of TTC patients, CSX patients and
      healthy volunteers with the following primary objective: to assess the response of
      endothelial function (through the Endopat score) to the autonomic tone activation induced by
      a 10-minute stress mental test. The assessment of autonomic tone during activation through
      the evaluation of Spontaneous BaRoreflex Sensitivity (BRS) and its correlation with
      endothelial function (Endopat score) will represent secondary objectives.

      Our study will enroll 15 patients with TTC at least six months after the event, 15 patients
      with classic CSX and 15 healthy volunteers who will serve as control.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in endothelial function in response to autonomic tone (Endopat score)</measure>
    <time_frame>Baseline</time_frame>
    <description>Difference in endothelial function assessed by Endopat score in response to autonomic tone induced by 10-minute mental stress test between the three groups (CSX, TTC, healty volunteers)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BaroReflex Sensitivity (Sensitivity measurement by volume-clamp method (Finapress)</measure>
    <time_frame>Baseline</time_frame>
    <description>Changes in BaroReflex Sensitivity from baseline in three three groups (CSX, TTC, healty volunteers)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BaroReflex Sensitivity and endothelial dysfunction (</measure>
    <time_frame>Baseline</time_frame>
    <description>Correlation with between BaroReflex Sensitivity [volume clamp method] and EndoPAT score in the three groups (CSX, TTC, healty volunteers)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial dysfunction (Changes in Endopat score)</measure>
    <time_frame>Baseline</time_frame>
    <description>Changes in Endopat score from baseline in three three groups (CSX, TTC, healty volunteers)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Syndrome X</condition>
  <condition>Takotsubo Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>Coronary X syndrome</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>BaroReflex Sensitivity, endothelial function measurement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tako-tsubo cardiomyopathy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>BaroReflex Sensitivity, endothelial function measurement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healty Volunteers</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>BaroReflex Sensitivity, endothelial function measurement</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>BaroReflex Sensitivity, endothelial function measurement</intervention_name>
    <description>no other</description>
    <arm_group_label>Coronary X syndrome</arm_group_label>
    <arm_group_label>Tako-tsubo cardiomyopathy</arm_group_label>
    <arm_group_label>Healty Volunteers</arm_group_label>
    <other_name>BaroReflex Sensitivity measurement by volume-clamp method (Finapress)</other_name>
    <other_name>Endothelial function measured by Endopat</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with the Mayo Clinic's criteria established diagnosis of TTC at least 6 month
             after the acute event

          -  Patients with CSX defined by the presence of anginal pain, positive exercise stress
             testing and negative coronary angiography.

          -  A comparable cohort of healthy volunteers age and sex-matched with patients

        Exclusion Criteria:

          -  Short-term life-threatening pathology (life expectancy &lt; 6 months)

          -  Physically unable to participate in the study

          -  Compliance not guaranteed

          -  Pregnancy

          -  Conditions that make BRS and Endopat measurements impossible
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Augusto Gallino, Prof MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni, Bellinzona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mattia Cattaneo, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni, Bellinzona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alessandra Pia Porretta, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni, Bellinzona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni, Bellinzona</name>
      <address>
        <city>Bellinzona</city>
        <state>Canton Ticino</state>
        <zip>6500</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2014</study_first_submitted>
  <study_first_submitted_qc>December 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2014</study_first_posted>
  <last_update_submitted>April 25, 2016</last_update_submitted>
  <last_update_submitted_qc>April 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale San Giovanni Bellinzona</investigator_affiliation>
    <investigator_full_name>Professor Augusto Gallino</investigator_full_name>
    <investigator_title>Professor MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Microvascular Angina</mesh_term>
    <mesh_term>Takotsubo Cardiomyopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

